SUMMARY REPORTS

COVID-19 causing acute kidney injury – ERACODA e-seminars series

Dialysis in AKI: indications, timing, type and more by Wim Van Biesen

High Altitude Medicine by Gianfranco Parati

HDF versus medium cut-off dialyzers by Francisco Maduell

Nutrition in patients with AKI: does it matter? by Enrico Fiaccadori

AKI in Covid-19 patients: mechanisms and management by Claudio Ronco

SGLT2 inhibition in CKD: Our chance to make a difference – Organised by CHANGE IME in partnership with Leicester Diabetes Centre, funded by an unrestricted educational grant from AstraZeneca

Clinical Conundrums in aTypical HUS – Organised by ALEXION PHARMA GMBH

K+: Recurrence, Restriction and Fluctuation. Organised by CHANGE IME in partnership with Leicester Diabetes Centre, funded by an unrestricted educational grant from AstraZeneca

COVID-19 Registry – the Spanish experience by Emilio Sanchez

COVID-19 and ACE inhibitors and ARBs by Patrick Mark

Small solute clearance: what are the pitfalls? by Enric Vilar

New therapeutic targets in Alport syndrome by Roser Torra

Phosphate toxicity in the kidney by Carsten Wagner

Vascular access : the Achilles tendon in HHD?

Which method to measure GFR and in which clinical conditions?

Outcomes of frail patients after kidney transplantation

ANCA-associated vasculitis in the elderly and very elderly

Inflammation in crystal nephropathies by Hans-Joachim Anders